Beyond the druggable proteome : unlocking new targets with BRETSA™
mar. 07 juil.
|PSCC, The Hive
Heure et lieu
07 juil. 2026, 08:45 – 10:00
PSCC, The Hive, 125 Rue Edouard Vaillant, 94800 Villejuif, France
À propos de l'événement
Join us for a breakfast ecosystem at the PSCC, bringing together researchers, biotech professionals, and industry experts at the Hive!
On July 7 we will be delighted to welcome Guillaume Herrault, Biotech Business Partner at Promega France on « Beyond the druggable proteome : unlocking new targets with BRETSA™ ».
This session will explore how to implement functional cell-based assays using Promega's innovative bioluminescence technologies, including the TarSeer™ BRETSA™ Target Engagement platform.
Join us on :
📍 PSCC, 125 rue Edouard Vaillant, 94800 Villejuif
🕘 08:45 – 10:00
🎟️ on-line or on-site tickets
Our speaker
Guillaume Herrault is a Biotech Business Partner at Promega France, supporting innovation across the French biotech ecosystem. Holding a PhD in cancer biology from the University of Bordeaux (BRIC/U1312), his doctoral work focused on drug repurposing and discovery in pediatric brainstem gliomas. He now partners with drug discovery teams — across small molecules, biologics, and cell & gene therapies
We are looking forward to the event.